Wei Yi Kong1, Qian Huang1, Peyton Thompson2, Brigid K Grabert3, Noel T Brewer3, Melissa B Gilkey4. 1. Department of Health Behavior, Gillings School of Global Public Health (WY Kong, Q Huang, BK Grabert, NT Brewer, MB Gilkey), University of North Carolina, Chapel Hill, NC. 2. Division of Infectious Diseases, Department of Pediatrics (P Thompson), University of North Carolina, Chapel Hill, NC. 3. Department of Health Behavior, Gillings School of Global Public Health (WY Kong, Q Huang, BK Grabert, NT Brewer, MB Gilkey), University of North Carolina, Chapel Hill, NC; Lineberger Comprehensive Cancer Center (BK Grabert, NT Brewer, MB Gilkey), University of North Carolina, Chapel Hill, NC. 4. Department of Health Behavior, Gillings School of Global Public Health (WY Kong, Q Huang, BK Grabert, NT Brewer, MB Gilkey), University of North Carolina, Chapel Hill, NC; Lineberger Comprehensive Cancer Center (BK Grabert, NT Brewer, MB Gilkey), University of North Carolina, Chapel Hill, NC. Electronic address: gilkey@email.unc.edu.
Abstract
OBJECTIVE: Several US health organizations, including the American Academy of Pediatrics, now encourage primary care professionals to recommend human papillomavirus (HPV) vaccination before the traditionally targeted ages of 11 to 12 years as a strategy to increase vaccination timeliness. To understand the feasibility of this approach, we sought to evaluate primary care professionals' current recommendation timing and willingness to recommend HPV vaccination at age 9. METHODS: A national sample of 1047 primary care professionals completed our online survey in 2021. Respondents were physicians (71%), advanced practitioners (17%), and nurses (12%). RESULTS: About one-fifth (21%) of primary care professionals reported that they already routinely recommend HPV vaccination at ages 9 to 10. Among the remaining 822 respondents, over half (61%) reported being somewhat or more willing to start recommending at age 9. Willingness was higher among those working in family medicine versus pediatrics (adjusted odds ratio [aOR]: 1.40, 95% confidence interval [CI] 1.03, 1.92), but lower among those with ≥20 years of practice experience versus ≤9 years (aOR: 0.65, 95% CI 0.44, 0.96). Many primary care professionals believed age 9 recommendations would have the advantage of protecting adolescents before HPV exposure (67%) or increasing vaccination timeliness (55%). The most commonly perceived disadvantage was that parents are not ready to talk about HPV vaccination at age 9 (73%). CONCLUSION: Over two-thirds of primary care professionals in our national sample reported they recommend HPV vaccination at ages 9 to 10 or are somewhat or more willing to do so. Training may be needed to help primary care professionals address perceived parental hesitancy toward age 9 recommendations.
OBJECTIVE: Several US health organizations, including the American Academy of Pediatrics, now encourage primary care professionals to recommend human papillomavirus (HPV) vaccination before the traditionally targeted ages of 11 to 12 years as a strategy to increase vaccination timeliness. To understand the feasibility of this approach, we sought to evaluate primary care professionals' current recommendation timing and willingness to recommend HPV vaccination at age 9. METHODS: A national sample of 1047 primary care professionals completed our online survey in 2021. Respondents were physicians (71%), advanced practitioners (17%), and nurses (12%). RESULTS: About one-fifth (21%) of primary care professionals reported that they already routinely recommend HPV vaccination at ages 9 to 10. Among the remaining 822 respondents, over half (61%) reported being somewhat or more willing to start recommending at age 9. Willingness was higher among those working in family medicine versus pediatrics (adjusted odds ratio [aOR]: 1.40, 95% confidence interval [CI] 1.03, 1.92), but lower among those with ≥20 years of practice experience versus ≤9 years (aOR: 0.65, 95% CI 0.44, 0.96). Many primary care professionals believed age 9 recommendations would have the advantage of protecting adolescents before HPV exposure (67%) or increasing vaccination timeliness (55%). The most commonly perceived disadvantage was that parents are not ready to talk about HPV vaccination at age 9 (73%). CONCLUSION: Over two-thirds of primary care professionals in our national sample reported they recommend HPV vaccination at ages 9 to 10 or are somewhat or more willing to do so. Training may be needed to help primary care professionals address perceived parental hesitancy toward age 9 recommendations.
Authors: Alexander G Fiks; Robert W Grundmeier; Stephanie Mayne; Lihai Song; Kristen Feemster; Dean Karavite; Cayce C Hughes; James Massey; Ron Keren; Louis M Bell; Richard Wasserman; A Russell Localio Journal: Pediatrics Date: 2013-05-06 Impact factor: 7.124
Authors: Mandy A Allison; Laura P Hurley; Lauri Markowitz; Lori A Crane; Michaela Brtnikova; Brenda L Beaty; Megan Snow; Janine Cory; Shannon Stokley; Jill Roark; Allison Kempe Journal: Pediatrics Date: 2016-01-04 Impact factor: 7.124
Authors: Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger Journal: MMWR Recomm Rep Date: 2007-03-23
Authors: Noel T Brewer; Megan E Hall; Teri L Malo; Melissa B Gilkey; Beth Quinn; Christine Lathren Journal: Pediatrics Date: 2016-12-05 Impact factor: 7.124
Authors: Rebecca B Perkins; Aaron Legler; Emily Jansen; Judith Bernstein; Natalie Pierre-Joseph; Terresa J Eun; Dea L Biancarelli; Thomas J Schuch; Karin Leschly; Anny T H R Fenton; William G Adams; Jack A Clark; Mari-Lynn Drainoni; Amresh Hanchate Journal: Pediatrics Date: 2020-06-15 Impact factor: 7.124